Co­herus restarts biosim­i­lar sup­ply af­ter de­lays; No­vavax ends Covid vac­cine deal with UK

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Co­herus is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.